The upcoming report from Jackson Financial (JXN) is expected to reveal quarterly earnings of $4.93 per share, indicating an increase of 16.6% compared to the year-ago period. Analysts forecast revenues of $1.78 billion, representing a decrease of 35.9% year over year.Over the last 30 days, there has been a downward revision of 10.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the ...

The upcoming report from American Financial Group (AFG) is expected to reveal quarterly earnings of $2.17 per share, indicating a decline of 21.4% compared to the year-ago period. Analysts forecast revenues of $1.94 billion, representing an increase of 2.9% year over year.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over t ...

Group 1 - Amerisafe reported $75.75 million in revenue for Q1 2025, a year-over-year decline of 0.3% [1] - The EPS for the same period was $0.60, down from $0.69 a year ago, with a surprise of +1.69% compared to the consensus estimate of $0.59 [1] - The revenue fell short of the Zacks Consensus Estimate of $76.83 million, resulting in a surprise of -1.41% [1] Group 2 - Key metrics indicate that Amerisafe's net investment income was $6.65 million, below the average estimate of $6.85 million, reflecting a year-over-year decline of 9.7% [4] - Fee and other income reached $0.21 million, exceeding the estimated $0.18 million, marking a significant increase of 70.7% compared to the previous year [4] - Net premiums earned were reported at $68.89 million, slightly below the average estimate of $69.81 million, with a year-over-year increase of 0.6% [4] Group 3 - Amerisafe's stock has returned -6.7% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The company currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Analysts on Wall Street project that Arch Capital Group (ACGL) will announce quarterly earnings of $1.37 per share in its forthcoming report, representing a decline of 44.1% year over year. Revenues are projected to reach $4.55 billion, increasing 20.8% from the same quarter last year. Analysts forecast 'Revenues- Net premiums earned' to reach $4.09 billion. The estimate indicates a change of +19.6% from the prior-year quarter. The consensus EPS estimate for the quarter has undergone a downward revision of ...

Core Insights - Elevance Health reported $48.77 billion in revenue for Q1 2025, a year-over-year increase of 15.4% and a surprise of +5.95% over the Zacks Consensus Estimate of $46.03 billion [1] - The EPS for the same period was $11.97, compared to $10.64 a year ago, with an EPS surprise of +6.78% against the consensus estimate of $11.21 [1] Revenue and Membership Metrics - Total Medical Membership stood at 45.83 million, slightly below the estimated 46.24 million [4] - Medicaid Medical Membership was 8.86 million, close to the estimate of 8.89 million [4] - Medicare Medical Membership was 876 thousand, exceeding the estimate of 866.49 thousand [4] - Commercial Risk-Based Medical Membership was 3.64 million, below the estimate of 3.75 million [4] Revenue Breakdown - Premium revenues reached $40.89 billion, surpassing the average estimate of $38.70 billion, reflecting a year-over-year change of +14.5% [4] - Service fees totaled $2.07 billion, slightly below the estimate of $2.13 billion, showing a -0.4% change year-over-year [4] - Net investment income was $590 million, exceeding the estimate of $461.32 million, with a year-over-year increase of +26.9% [4] - Product revenue was $5.81 billion, above the estimate of $5.11 billion, representing a +29.1% change year-over-year [4] Operating Revenue Performance - Total operating revenue from Carelon Services was $6.54 billion, exceeding the estimate of $5.87 billion, with a year-over-year change of +63% [4] - CarelonRx generated $10.12 billion in operating revenue, surpassing the estimate of $9.40 billion, reflecting a +25.4% change year-over-year [4] - Health Benefits operating revenue was $41.43 billion, above the estimate of $39.82 billion, with a year-over-year increase of +11.2% [4] - Carelon's total operating revenue was $16.65 billion, exceeding the estimate of $15.27 billion, representing a +37.9% change year-over-year [4]

Core Insights - Wall Street analysts forecast Kinsale Capital Group, Inc. (KNSL) will report quarterly earnings of $3.15 per share, reflecting a year-over-year decline of 10% and revenues of $424.32 million, which is an increase of 13.8% compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.2% lower over the last 30 days, indicating a collective reevaluation by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - The consensus estimate for 'Revenues- Net investment income' is $43.84 million, indicating a year-over-year change of +33.1% [5] - 'Revenues- Net Earned Premiums' is projected to reach $370.83 million, reflecting a change of +5.6% from the prior-year quarter [5] - 'Revenues- Fee Income' is expected to be $9.37 million, showing a year-over-year change of +15.8% [5] Expense and Ratio Estimates - Analysts predict the 'Expense Ratio' will reach 21.0%, up from 20.7% in the same quarter last year [6] - The 'Combined Ratio' is expected to be 86.9%, compared to 79.5% a year ago [6] - The average prediction for the 'Loss Ratio' is 65.9%, an increase from 58.8% in the previous year [6] Stock Performance - Kinsale Capital Group shares have returned +5.8% over the past month, contrasting with the Zacks S&P 500 composite's -6.9% change [7] - The company holds a Zacks Rank 4 (Sell), suggesting it may underperform the overall market in the near future [7]